• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, October 1, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Research identifies possible new pathway to treatment of colorectal cancer

Bioengineer by Bioengineer
June 17, 2024
in Chemistry
Reading Time: 3 mins read
0
(From left) Kristin Eden, Brie Trusiano, and Irving Coy Allen.
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Research led by Irving Coy Allen in the Virginia-Maryland College of Veterinary Medicine has unlocked a pathway to possible future treatments for colorectal cancer in humans.

(From left) Kristin Eden, Brie Trusiano, and Irving Coy Allen.

Credit: Photo by Madison Brown for Virginia Tech.

Research led by Irving Coy Allen in the Virginia-Maryland College of Veterinary Medicine has unlocked a pathway to possible future treatments for colorectal cancer in humans.

A paper published in May in the American Gastroenterological Association journal Cellular and Molecular Gastroenterology and Hepatology focuses on NF-kB-inducing kinase (NIK) and its importance in triggering cellular responses that reduce the risk of the development of colorectal cancer.

“The gene itself is colloquially called NIK, and it encodes a protein that is a kinase, which means it basically turns on or turns off – mostly turns on – lots of different genes and pathways,” said Allen, professor of inflammatory diseases in the Department of Biomedical Sciences and Pathology.  “It gives us a central spoke in a hub of biological mechanisms that can be targeted with possible therapeutics. We do know that there are companies working on developing drugs to target NIK. We’re hoping that this can provide them with incentive to go after these drug candidates more aggressively.”

Colorectal cancer is second deadliest form of cancer in the United States, killing over 52,000 people in 2023. Present treatment options are often based on chemotherapy and can be difficult for the patient to endure. 

“By identifying new markers and new drug targets, it may provide us with better therapeutic approaches that can minimize side effects and improve overall patient outcomes,” Allen said. 

While much of the study was conducted examining mice, and that alone could have generated valuable research, Allen’s team took the extra step of translating it directly to human patients.

“By modeling it in mice, we were able to identify things to look for in humans,” Allen said.  “Through collaboration with the Duke University Medical Center and colleagues here at the Virginia Tech Carilion School of Medicine, we were able to get human specimens to confirm that what we were observing in the mouse models was also true in in human colorectal cancer patients.”

The medical application of the findings will be determined in years to come as other researchers seek to identify treatments that can target NIK and its interactions with other proteins.

“Our study identified changes in a significant signaling pathway in human patients,” Allen said. “That presents a variety of possible targets that have not been previously evaluated in that pathway where you could potentially design therapeutics.”

Publication of the paper represents the conclusion of a lengthy study for Allen. Graduate students Kristin Eden ’06, DVM ’10, Ph.D. ’18; Holly Morrison Ph.D. ’23; and Brie Trusiano Ph.D. ’24 took turns helping Allen with the research and carrying it to the finish line.

“When I first came here 12 years ago, my postdoctorate work had identified some hints that this pathway might be important in the context of colorectal cancer and also in the context of inflammatory bowel disease,” Allen said. “Completion of this work has been very satisfying, knowing that it helped to launch the careers of these three talented graduate students and several undergraduate researchers as well.”

Allen said because his studies on the NIK pathway in colorectal cancer are concluded, he and his team will turn toward other types of cancer impacted by NIK and the signaling pathways it controls. But he hopes others can carry the findings forward for life-saving improvements in colorectal cancer treatment.



Journal

Cellular and Molecular Gastroenterology and Hepatology

Article Title

NF-κB Inducing Kinase Attenuates Colorectal Cancer by Regulating Noncanonical NF-κB Mediated Colonic Epithelial Cell Regeneration

Article Publication Date

13-May-2024

Share12Tweet8Share2ShareShareShare2

Related Posts

Dual Dynamic Helical Poly(disulfide)s: Adaptive, Recyclable Polymers

Dual Dynamic Helical Poly(disulfide)s: Adaptive, Recyclable Polymers

October 1, 2025
Atom-photon entanglement breakthrough opens new horizons for future quantum networks

Atom-photon entanglement breakthrough opens new horizons for future quantum networks

September 30, 2025

Charting the Cosmos Made Simpler

September 30, 2025

Scientists Discover Room-Temperature Method to Enhance Light-Harvesting and Emission Devices

September 30, 2025

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    89 shares
    Share 36 Tweet 22
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    62 shares
    Share 25 Tweet 16
  • Scientists Discover and Synthesize Active Compound in Magic Mushrooms Again

    57 shares
    Share 23 Tweet 14

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Urban Quality of Life in Africa: Policy vs Reality

Scaling Sustainable Cacao Farming in Colombia

Polygenic Risk Scores Vary Across Populations in Diabetes

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.